{
  "id": "621215ec3a8413c653000012",
  "type": "list",
  "question": "What types of anti-tumor therapeutic antibodies are available?",
  "ideal_answer": "Anti-tumor therapeutic antibodies include single-targeted antibodies, bi-specific antibodies (BsAbs), and antibody-drug conjugates (ADCs).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32370812"
  ],
  "snippets": [
    {
      "text": "Therefore, when developing anti-tumor therapeutic antibodies, including single-targeted antibodies, bi-specific antibodies (BsAbs), and antibody-drug conjugates (ADCs), many factors, such as target biology, cellular distribution of the targets, the environments of particular tumor types, as well as the proposed mechanism of action (MOA), must be taken into consideration. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32370812",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "single-targeted antibodies, bi-specific antibodies, BsAbs, antibody-drug conjugates, ADCs"
}